A new asthma spacer device to improve compliance in children: a pilot study

Gervase Chaney1, Barry Clements, Lou Landau

  • 1Princess Margaret Hospital for Children, The University of Western Australia, Perth, Western Australia, Australia.

Respirology (Carlton, Vic.)
|December 23, 2004
PubMed

Insights

The Funhaler, a new incentive spacer device, significantly improved medication success and adherence in children with asthma compared to existing devices. This led to better child and parental attitudes toward treatment, warranting further trials.

Area of Science:

  • Pediatric Respiratory Medicine
  • Medical Device Innovation
  • Adherence Research

Background:

  • Asthma medication adherence in children is often poor due to challenges with existing inhaler devices.
  • Spacer devices are crucial for effective delivery of inhaled medications in pediatric asthma management.
  • Improving adherence is key to optimizing treatment outcomes and reducing exacerbations.

Purpose of the Study:

  • To compare the acceptance, ease of use, and compliance effects of the Funhaler versus standard spacer devices in children.
  • To evaluate the Funhaler's potential to enhance adherence to asthma medication in a pediatric population.

Main Methods:

  • A pilot study involving 32 preschool children (1.5-6 years) with asthma using inhaled medication.
  • Matched questionnaire surveys administered to caregivers before and after a 2-week trial of the Funhaler.
  • Data collection focused on ease of use, child/parental compliance, and treatment attitudes.

Main Results:

  • Parents reported significantly higher success rates medicating children with the Funhaler (22/30) compared to existing spacers (3/30).
  • The Funhaler demonstrated improved parental adherence to prescribed frequency and delivery technique.
  • Children showed increased satisfaction and willingness to use the Funhaler, with improved parental attitudes toward medication.

Conclusions:

  • The novel Funhaler incentive spacer device shows promise in improving medication success, adherence, and treatment attitudes in children with asthma.
  • Findings suggest the Funhaler may overcome common barriers to inhaled medication use in pediatric patients.
  • Further long-term efficacy trials are recommended to confirm the benefits of the Funhaler.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma